首页> 外文期刊>Nutrition, metabolism, and cardiovascular diseases: NMCD >Homocysteine and post-angioplasty restenosis.
【24h】

Homocysteine and post-angioplasty restenosis.

机译:同型半胱氨酸和血管成形术后再狭窄。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To review the effect of moderate hyperhomocysteinemia on restenosis after coronary angioplasty. DATA SUMMARY: Hyperhomocysteinemia is associated with arterial neointimal proliferation in subjects with homocystinuria, atherosclerosis and coronary graft disease. In the rat model, it exacerbates neointimal proliferation after carotid injury. In humans, restenosis after coronary angioplasty is inconsistently associated with hyperhomocysteinemia. A large clinical trial has shown that the administration of folic acid lowers homocysteinemia and the risk of restenosis after coronary angioplasty. CONCLUSION: Hyperhomocysteinemia is probably a weak risk factor for coronary restenosis after angioplasty, although it is still difficult to ascertain whether homocysteine plays a causative role in restenosis. Further studies of restenosis prevention after coronary stenting are necessary before the routine post-angioplasty administration of folic acid can be recommended.
机译:目的:探讨中度高同型半胱氨酸血症对冠状动脉成形术后再狭窄的影响。数据摘要:高同型半胱氨酸血症与高半胱氨酸尿症,动脉粥样硬化和冠状动脉移植疾病的受试者的动脉内膜增生有关。在大鼠模型中,它会加剧颈动脉损伤后的新内膜增生。在人类中,冠状动脉成形术后的再狭窄与高同型半胱氨酸血症不一致。一项大型的临床试验表明,叶酸的施用降低了高半胱氨酸血症和冠状动脉成形术后的再狭窄风险。结论:高同型半胱氨酸血症可能是血管成形术后冠状动脉再狭窄的弱风险因素,尽管仍难以确定同型半胱氨酸是否在再狭窄中起因。在建议常规血管成形术后给予叶酸之前,有必要进一步研究冠状动脉支架置入术后再狭窄的预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号